Varex Imaging (VREX) SVP Garcia details stock, RSU and option holdings

Rhea-AI Filing Summary

Varex Imaging Corp senior vice president of regulatory and quality assurance Victor Hugo Garcia filed a Form 3 detailing his existing equity stake in the company. The filing shows direct ownership of 23,360 shares of common stock, along with multiple blocks of restricted stock units, performance stock units, and non-qualified stock options. These derivative awards cover underlying common shares at exercise prices ranging from $22.13 to $31.42, with option expirations extending through December 8, 2032. The entries reflect current holdings rather than new open‑market purchases or sales.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Garcia Victor Hugo

(Last) (First) (Middle)

C/O VAREX IMAGING CORP,

1678 S. PIONEER ROAD

(Street)

SLC UTAH 84104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/13/2026

3. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Regulatory and QA

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,360	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Common Stock	4,970	(2)	D
Restricted Stock Units	(3)	(3)	Common Stock	5,079	(2)	D
Restricted Stock Units	(4)	(4)	Common Stock	9,190	(2)	D
Restricted Stock Units	(5)	(5)	Common Stock	16,666	(2)	D
Performance Stock Units	(6)	(6)	Common Stock	2,673	(7)	D
Performance Stock Units	(8)	(8)	Common Stock	2,004	(7)	D
Non-Qualified Stock Option (right to buy)	(9)	02/15/2026	Common Stock	11,776	$31.42	D
Non-Qualified Stock Option (right to buy)	(10)	02/15/2030	Common Stock	14,013	$28.12	D
Non-Qualified Stock Option (right to buy)	(11)	02/16/2031	Common Stock	13,426	$25.06	D
Non-Qualified Stock Option (right to buy)	(12)	12/10/2031	Common Stock	12,427	$30.95	D
Non-Qualified Stock Option (right to buy)	(13)	12/08/2032	Common Stock	20,597	$22.13	D

Explanation of Responses:

1. These Restricted Stock Units granted on December 9, 2022 vested 50% on December 10, 2024, with the remaining 50% scheduled to vest on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date.

2. Each Restricted Stock Unit converts into common stock on a one-for-one basis.

3. These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

4. These Restricted Stock Units granted on December 10, 2024 vest 50% on December 10, 2026 and 50% on December 10, 2028. Vested shares will be delivered to the reporting person upon vest date.

5. These Restricted Stock Units granted on December 10, 2025 vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

6. On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned as a result of the achievement of such performance criteria for fiscal year 2024 and 2025. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

7. Each PSU represents a contingent right to receive one share of Issuer common stock, subject to the achievement of applicable performance criteria.

8. On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

9. These Non-Qualified Stock Options, granted on February 15, 2019 are subject to a four-year vesting schedule. 25% of the total number of options vested on February 15, 2020, with the remaining options vesting monthly thereafter on the 15th day of each month on a pro rata basis. These options expired unexercised on February15, 2026

10. These Performance Stock Options, granted on February 18, 2020, are subject to a four-year vesting schedule. 25% of the total number of options vested on February 15, 2021, with the remaining options vesting monthly thereafter on the 15th day of each month on a pro rata basis.

11. These Performance Stock Options, granted on February 16, 2021, are subject to a four-year vesting schedule. 25% of the total number of options vested on February 15, 2022, with the remaining options vesting monthly thereafter on the 15th day of each month on a pro rata basis.

12. These Performance Stock Options, granted on December 10, 2021, are subject to a four-year vesting schedule. 25% of the total number of options vested on December 10, 2022, with the remaining options vesting monthly thereafter on the 10th day of each month on a pro rata basis.

13. These Performance Stock Options, granted on December 9, 2022, are subject to a four-year vesting schedule. 25% of the total number of options vested on December 10, 2023, with the remaining options vesting monthly thereafter on the 10th day of each month on a pro rata basis.

Remarks:

	/s/ Victor H. Garcia	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Victor Hugo Garcia’s Form 3 show for Varex Imaging (VREX)?

The Form 3 shows Victor Hugo Garcia’s existing equity stake in Varex Imaging, including 23,360 common shares and multiple grants of restricted stock units, performance stock units, and stock options covering additional common shares at specified exercise prices and expirations.

Did Victor Hugo Garcia buy or sell VREX shares in this Form 3 filing?

The filing does not report new open‑market purchases or sales. It lists Garcia’s current holdings in common stock, restricted stock units, performance stock units, and non‑qualified stock options as of the reporting date, serving as an initial ownership snapshot.

What stock option positions does Victor Hugo Garcia hold in Varex Imaging (VREX)?

Garcia holds several non‑qualified stock option grants over Varex Imaging common stock, with exercise prices including $31.42, $28.12, $25.06, $30.95, and $22.13 per share, and expiration dates running from February 2026 through December 8, 2032, subject to vesting terms.

How are Victor Hugo Garcia’s RSUs in Varex Imaging (VREX) structured?

His restricted stock units convert into Varex Imaging common stock on a one‑for‑one basis. They vest in 50% tranches on scheduled dates such as December 10, 2026, 2027, 2028, and 2029, with vested shares delivered on each vesting date if he remains employed.

What performance stock units does Victor Hugo Garcia have tied to VREX?

Garcia’s performance stock units represent rights to receive Varex Imaging common shares if performance criteria are met. Footnotes explain that PSU quantities earned are based on results for fiscal years 2024, 2025, and later 2026–2027, with vesting subject to continued employment through the vesting date.

What role does Victor Hugo Garcia hold at Varex Imaging (VREX)?

In this filing, Victor Hugo Garcia is identified as an officer of Varex Imaging serving as senior vice president, regulatory and quality assurance. The Form 3 records his direct ownership of common stock and equity awards associated with his executive compensation package.